Company Filing History:
Years Active: 2018
Title: Innovations by Pascal Prinderre
Introduction
Pascal Prinderre is a notable inventor based in Muespach, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new dosage forms for poorly soluble drugs. With a total of two patents to his name, Prinderre's work is recognized for its potential to improve drug delivery and efficacy.
Latest Patents
Prinderre's latest patents include innovative pharmaceutical formulations. The first patent focuses on mesoporous dosage forms for poorly soluble drugs. This invention is directed to a new pharmaceutical dosage form comprising mesoporous particles loaded with a poorly soluble active pharmaceutical ingredient. The particles are at least partially, preferably homogeneously, covered with a polymer solid dispersion. The second patent describes oral pharmaceutical formulations that consist of a core component and a coating composition applied on the core component. Additionally, it outlines a process for producing these oral pharmaceutical formulations.
Career Highlights
Pascal Prinderre is currently associated with Siegfried Aktiengesellschaft, a company known for its expertise in pharmaceutical manufacturing. His role at the company allows him to leverage his innovative ideas and contribute to the advancement of pharmaceutical technologies.
Conclusion
Pascal Prinderre's work exemplifies the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to enhancing drug formulations, which can lead to better patient outcomes.